Phase 1 study of the PI3K{delta} inhibitor INCB040093 {+/-} JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Phillips, T. J., Forero-Torres, A., Sher, T., Diefenbach, C. S., Johnston, P., Talpaz, M., Pulini, J., Zhou, L., Scherle, P., Chen, X., Barr, P. M.
American Society of Hematology (ASH)
Published 2018
American Society of Hematology (ASH)
Published 2018
| Publication Date: |
2018-07-20
|
|---|---|
| Publisher: |
American Society of Hematology (ASH)
|
| Print ISSN: |
0006-4971
|
| Electronic ISSN: |
1528-0020
|
| Topics: |
Biology
Medicine
|
| Keywords: |
Lymphoid Neoplasia, Clinical Trials and Observations
|
| Published by: |